Drug Trial Radar · NCT07175428
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,200
Planned (sponsor's estimate)
Start
Oct 20, 2025
Primary completion
Feb 9, 2027
Study completion Apr 21, 2027
Sponsor
- Lead sponsor
- Regeneron PharmaceuticalsRegeneron (REGN)
- Sponsor type
- Industry
- First posted
- Sep 16, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is researching experimental drugs called REGN7508 and REGN9933. The study is focused on participants who have atrial fibrillation, which means that the heart beats too fast and unevenly. REGN7508 and REGN9933 are designed to help stop blood clots forming in patients with atrial fibrillation. The aim of the study is to see how well REGN7508 and REGN9933 work in patients that get medicine for their atrial fibrillation. The bleeding effects of REGN7508 and REGN9933 will be compared to another medicine (apixaban), which is available on the market to treat and prevent formation of blood clots. The study is looking at several other research questions, including: * What side effects may happen from taking REGN7508 or REGN9933 * How well do the study drugs reduce the risk of having a stroke * How much of REGN7508 or REGN9933 is in the blood at different times * Whether the body makes antibodies against REGN7508 or REGN9933 (which could make the drugs less effective or could lead to side effects)
Conditions
- Atrial Fibrillation (AF)
Interventions
REGN7508Drug
Administered per the protocol
REGN9933Drug
Administered per the protocol
ApixabanDrug
Administered per the protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of any bleedingTime frame: 12 weeks
Locations
91 sites in 4 countries. Site status is shown where the registry gives one.
SEC Clinical Research
Dothan, Alabama · Recruiting
Eastern Shore Research Institute
Fairhope, Alabama · Recruiting
Valley Clinical Trials, Inc
Covina, California · Recruiting
North Coast Cardiology
Encinitas, California · Recruiting
Mission Cardiovascular Research Institute
Fremont, California · Recruiting
National Institute of California Heart and Vein Specialists
Huntington Beach, California · Recruiting
Profound Research LLC at Southern California Heart Specialists
Pasadena, California · Recruiting
Empire Clinical Research
Pomona, California · Recruiting
The Cardiovascular Center
Redding, California · Recruiting
Northbay Clinical Research Center
Santa Rosa, California · Recruiting
Cardiology Associates Medical Group
Ventura, California · Recruiting
Interventional Cardiology Medical Group
West Hills, California · Recruiting
Nouvelle Clinical Research LLC
Cutler Bay, Florida · Recruiting
South Florida Research Organization LLC
Medley, Florida · Recruiting
Inpatient Research Clinic LLC
Miami Lakes, Florida · Recruiting
Cardiovascular Center of Sarasota Foundation for Research and Education
Sarasota, Florida · Recruiting
Clinical Site Partners, LLC DBA Flourish Research
Winter Park, Florida · Recruiting
Grady Health System
Atlanta, Georgia · Recruiting
Health Sciences Research Building II
Atlanta, Georgia · Withdrawn
NSC Research, Inc
Johns Creek, Georgia · Recruiting
Indiana University
Indianapolis, Indiana · Recruiting
Blue Coast Research Center, LLC
Indianapolis, Indiana · Recruiting
Franciscan Physician Network, Indiana Heart Physicians
Indianapolis, Indiana · Recruiting
Indiana Medical Research
Merrillville, Indiana · Recruiting
Reid Physician Associates
Richmond, Indiana · Recruiting
Monroe Research, LLC
West Monroe, Louisiana · Recruiting
Anderson Medical Research
Ft. Washington, Maryland · Recruiting
Beth Israel Lahey Health, Beth Israel Deaconess Medical Center (BIDMC)
Boston, Massachusetts · Recruiting
Profound Research, Millennium Cardiology
Farmington Hills, Michigan · Recruiting
AA Medical Research Center (MRC)
Flint, Michigan · Recruiting
Fairview Health Services
Maplewood, Minnesota · Recruiting
Moses Cone Hospital Operating Corporation dba Cone Health, Lebauer-Brodie Center for Cardiovascular Research
Greensboro, North Carolina · Recruiting
K&R Research LLC
Marion, Ohio · Recruiting
Advanced Medical Research
Maumee, Ohio · Recruiting
Monument Health Clinical Research
Rapid City, South Dakota · Recruiting
East Coast Institute for Research, Jefferson City
Jefferson City, Tennessee · Recruiting
PharmaTex Research
Amarillo, Texas · Recruiting
Complete Heart Care P.A.
McKinney, Texas · Recruiting
Texas Institute of Cardiology PA
McKinney, Texas · Recruiting
Synergy Group Medical, LLC
Missouri City, Texas · Recruiting
Showing 40 of 91 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.